Morphic announces participation in 2023 wells fargo healthcare conference

Waltham, mass., aug. 29, 2023 (globe newswire) -- morphic therapeutic (nasdaq: morf), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that marc schegerin, md, coo & cfo, will participate in a fireside chat at the wells fargo healthcare conference on wednesday, september 6th at 8:00 am et.
MORF Ratings Summary
MORF Quant Ranking